Beta Bionics appoints Gerard Michel as Class III director

Beta Bionics, Inc.

Gerard Michel appointed to board effective March 26, 2025; term expires at 2028 annual meeting.
Michel currently CEO of Delcath Systems; former CFO of Vericel, Biodel, and NPS Pharmaceuticals.
Annual cash retainer of $50,000; initial RSU grant of 12,547 shares vesting on one-year anniversary.
No material arrangements or transactions with Michel requiring disclosure under Item 404(a).

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Gerard Michel

Class III director

BBNX · Beta Bionics, Inc.

Effective: 2025-03-26
Filed: March 27, 2025, 7:59 PM ET

On March 26, 2025, the Board of Directors (the “Board”) of Beta Bionics, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Gerard Michel as a Class III director of the Company, with a term of office expiring at the 2028 annual meeting of stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Gerard Michel was appointed as Class III director at Beta Bionics, Inc..

Action: appointed
Role: Class III director

Exact text from the filing

On March 26, 2025, the Board of Directors (the “Board”) of Beta Bionics, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Gerard Michel as a Class III director of the Company, with a term of office expiring at the 2028 annual meeting of stockholders.

View on SEC.gov

Beta Bionics, Inc. filing history →

Source: SEC EDGAR

accession 0001171843-25-001785

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.